Purpose: Primary objective is to evaluate clinical and pathological response at both primary and neck and margin status and postoperative morbidity in T4 resectable oral cavity cancer patients treated with neo adjuvant chemo-radiotherapy.
No takes yet. Share an insight, caveat, or question.
Sushmitha et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: